8.28
Schlusskurs vom Vortag:
$8.47
Offen:
$8.25
24-Stunden-Volumen:
56,616
Relative Volume:
0.73
Marktkapitalisierung:
$477.64M
Einnahmen:
$180.46M
Nettoeinkommen (Verlust:
$20.20M
KGV:
23.88
EPS:
0.3468
Netto-Cashflow:
$16.59M
1W Leistung:
+2.60%
1M Leistung:
-6.55%
6M Leistung:
+23.58%
1J Leistung:
+38.23%
Kamada Ltd Stock (KMDA) Company Profile
Compare KMDA vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
KMDA
Kamada Ltd
|
8.28 | 488.60M | 180.46M | 20.20M | 16.59M | 0.3468 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.22 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
118.26 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
9.92 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.82 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
559.65 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-21 | Eingeleitet | The Benchmark Company | Buy |
| 2024-07-03 | Eingeleitet | Stifel | Buy |
| 2018-02-02 | Eingeleitet | Chardan Capital Markets | Buy |
Kamada Ltd Aktie (KMDA) Neueste Nachrichten
KMDA SEC FilingsKamada Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
KMDA PE Ratio & Valuation, Is KMDA Overvalued - Intellectia AI
Kamada Ltd Earnings Call Signals Confident Growth Path - tipranks.com
Kamada obtains Israeli tax ruling for $14.4M dividend payment By Investing.com - au.investing.com
Kamada (KMDA) Secures Favorable Tax Ruling on Cash Dividend - gurufocus.com
Kamada Details Israeli Withholding Terms for April 7 Cash Dividend - tipranks.com
Kamada (NASDAQ: KMDA) outlines Israeli tax relief on $0.25 dividend - Stock Titan
Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders - ChartMill
Kamada: From Buy To Hold After 22.4% Surge (Rating Downgrade) (NASDAQ:KMDA) - Seeking Alpha
Kamada’s San Antonio plasma center wins FDA approval By Investing.com - Investing.com South Africa
Aug PreEarnings: Can Kamada Ltd continue delivering strong returns2026 Short Interest & Community Trade Idea Sharing - baoquankhu1.vn
Kamada (KMDA) Gains FDA Approval for San Antonio Plasma Center - gurufocus.com
Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas - Bitget
FDA Approves Kamada's (KMDA) Plasma Collection Facility in Texas - gurufocus.com
Kamada Wins FDA Nod for High-Capacity San Antonio Plasma Center - TipRanks
Kamada’s San Antonio plasma center wins FDA approval - Investing.com
FDA clears Kamada (NASDAQ: KMDA) San Antonio plasma collection center - Stock Titan
Earnings call transcript: Kamada Ltd. misses Q4 2025 forecasts, stock dips - Investing.com Australia
Earnings call transcript: Kamada Ltd. misses Q4 2025 forecasts, stock dips By Investing.com - za.investing.com
Kamada shares drop as company halts Phase 3 study of inhaled AAT therapy - msn.com
KMDA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Kamada (KMDA) director and 10% owner details 22M shares and options - Stock Titan
Kamada Ltd.: - marketscreener.com
Analyst Downgrade: Can Kamada Ltd benefit from deglobalizationTrade Analysis Summary & High Win Rate Trade Alerts - baoquankhu1.vn
Market Rankings: Is Kamada Ltd exposed to political risk2026 Geopolitical Influence & Short-Term High Return Ideas - baoquankhu1.vn
Kamada Shifts $14.4 Million Dividend Payment Date to April 7, 2026 - TipRanks
Kamada (NASDAQ: KMDA) moves $0.25 dividend payment to April 7, 2026 - Stock Titan
Kamada (KMDA) director Lilach Payorski reports options over 30,000 shares - Stock Titan
Benjamin Dekel Net Worth (2026) - gurufocus.com
David Tsur Net Worth (2026) - GuruFocus
Amir London Net Worth (2026) - GuruFocus
Kamada Ltd Stock (ISIN: IL0010952647) Faces Headwinds Amid Plasma Supply Challenges - AD HOC NEWS
Kamada Ltd. (NASDAQ:KMDA) Short Interest Down 17.8% in February - MarketBeat
Kamada director reports option holdings on Form 3 | KMDA SEC FilingForm 3 - Stock Titan
Leon Recanati controls 6.04% of Kamada (NASDAQ: KMDA) in amended 13G/A - Stock Titan
Kamada (KMDA) VP Boris Gorelik details structured stock option grants - Stock Titan
Kamada (KMDA) CEO Amir London details shares and option grants - Stock Titan
Kamada (KMDA) VP Regulatory Affairs reports initial shares and option grants - Stock Titan
Kamada (KMDA) VP Shavit reports ordinary shares and option grants - Stock Titan
Kamada (NASDAQ: KMDA) VP reports initial share and option holdings - Stock Titan
Director David Tsur details Kamada (KMDA) share and option stakes - Stock Titan
Kamada (KMDA) VP Nir Eran discloses initial share and option holdings - Stock Titan
Kamada (KMDA) VP Quality details ordinary share and option holdings - Stock Titan
Kamada (KMDA) VP Human Resources reports direct stock option holdings - Stock Titan
Kamada (KMDA) director files Form 3 detailing multiple option grants - Stock Titan
Kamada (KMDA) CFO reports holdings of Ordinary Shares and options - Stock Titan
Leon Recanati details Kamada (KMDA) share and option stakes - Stock Titan
Kamada (KMDA) VP Jon Knight details multiple stock option holdings - Stock Titan
Kamada (KMDA) director discloses multiple stock option grants - Stock Titan
HC Wainwright Predicts Kamada's Q1 Earnings (NASDAQ:KMDA) - MarketBeat
HC Wainwright Predicts Kamada’s Q1 Earnings (NASDAQ:KMDA) - Defense World
Finanzdaten der Kamada Ltd-Aktie (KMDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):